Electroacupuncture restores intestinal mucosal barrier through TLR4/NF‐κB p65 pathway in functional dyspepsia‐like rats
- 29 October 2021
- journal article
- research article
- Published by Wiley in The Anatomical Record
- Vol. 306 (12) , 2927-2938
Abstract
Functional dyspepsia (FD) is a common functional gastrointestinal disorder with high morbidity. Electroacupuncture (EA) has been applied to treat FD for a long time. The aim of this study was to investigate the effects of EA and its mechanism about intestinal mucosal barrier in rodent model of FD. Male Sprague–Dawley rats were randomly divided into the control group and the model group. Then, the rats in model group were established to the FD model by multifactor interventions. In Experiment 1, qualified FD‐like rats were randomly divided into three groups: FD, EA, and acupuncture (AP) groups. The interventions of EA and AP lasted 14 days, food intake, and body weight were recorded every 5 days. In Experiment 2, qualified FD‐like rats were randomly divided into five groups: FD, EA, AP, EA + TAK242, and TAK242 groups. The interventions of EA and AP lasted 14 days, while TAK242 injection continued for 6 days. The rats were sacrificed for the measurement of serum Interleukin‐ 6 (IL‐6) and Tumor necrosis factor‐α (TNF‐α) assayed by ELISA. Western blotting was used to assess the expression of TLR4, Myd88, NF‐κB p65, p‐NF‐κB p65, TRAF6, ZO‐1, and occludin in the duodenum. The transmission electron microscope was used to observe the ultrastructure of intestinal epithelial cells. Compared with the rats in the group FD, the rats in EA group had significantly increase of body weight, food intake, and protein expressions of ZO‐1 and occludin, while expressions of TLR4, Myd88, NF‐κB p65, p‐NF‐κB p65, TRAF6 in the duodenum and IL‐6, and TNF‐α in serum were decreased. The EA + TAK242 treatment had similar effects to the EA treatment but with increased potency; compared with EA, AP showed similar but reduced effects. Our data demonstrated that EA is more effective than AP in improving intestine mucosal barrier. The possible mechanisms of EA may involve the TLR4/NF‐κB p65 pathway.Keywords
Funding Information
- National Natural Science Foundation of China (82060897, 81674072, 81473790)
This publication has 49 references indexed in Scilit:
- Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stressJournal of Neuroinflammation, 2014
- Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsiaGut, 2013
- Functional dyspepsia—symptoms, definitions and validity of the Rome III criteriaNature Reviews Gastroenterology & Hepatology, 2013
- Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microgliaJournal of Neuroinflammation, 2013
- Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel SyndromeJournal of Clinical Gastroenterology, 2012
- A Long-Term Study of Acotiamide in Patients with Functional Dyspepsia: Results from an Open-Label Phase III Trial in Japan on Efficacy, Safety and Pattern of AdministrationDigestion, 2011
- Impact of Functional Gastrointestinal Disorders on Survival in the CommunityAmerican Journal of Gastroenterology, 2010
- Dysaccommodation of the stomach: therapeutic nirvana?Neurogastroenterology & Motility, 2006
- A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular SignalingMolecular Pharmacology, 2006
- Functional Gastroduodenal DisordersGastroenterology, 2006